Dr. Nicholas Cost is a testicular cancer specialist and he also serves on our Medical Advisory Board. He has been instrumental and incredibly generous in helping us answer difficult questions for those needing help.
Now he could use our help having testicular cancer survivors complete his super short survey. Specifically, he is looking for guys that have had seminoma for his seminoma survey. See his letter below.
I took the survey and it lasted about 2 minutes.
Mike
Dear Testicular Cancer Society Members,
First of all, thank you for your time! Testicular cancer represents one of the true “success stories” for modern cancer treatment with almost all newly diagnosed patients being cured. With such successful outcomes, the focus has now turned to a reduction in the treatment’s side-effects. We are interested in investigating the use of a different method of treating a particular type of testicular cancer, called testicular seminoma, in an attempt to help decrease the side-effects from treatment while preserving the excellent chance for cure.
You are being asked to participate in this survey because you are a member of the Testicular Cancer Society. Participation is voluntary and there is no immediate benefit to you. This survey is designed to help us understand the potential interest in this issue and help in future study design. If you participate in the survey, your consent to participate in this study is conferred by clicking on the link to the survey. To insure your privacy and confidentiality, your responses to this survey will be de-identified and kept anonymous. The survey data will be used both for developing future clinical trials and potential future publication. If you agree to participate in our survey this in no way implies that you would be a patient in such a clinical trial in the future. We are only asking for your response to help us understand what percentage of patients would be interested in such a study.
This study has been granted exempt-status by the University of Colorado Multiple Institutional Review Board. If you have questions about your rights as someone in this study, you are welcome to call the Colorado Multiple Institutional Review Board at (303)724-1055.
Thank you again for your time, and hopefully your participation! Please feel free to contact us using the email address below if there are any questions or concerns.
The link to the survey is as follows: https://www.surveymonkey.com/r/98WCFGQ
Sincerely,
Nicholas Cost, MD
University of Colorado Cancer Center
Now he could use our help having testicular cancer survivors complete his super short survey. Specifically, he is looking for guys that have had seminoma for his seminoma survey. See his letter below.
I took the survey and it lasted about 2 minutes.
Mike
Dear Testicular Cancer Society Members,
First of all, thank you for your time! Testicular cancer represents one of the true “success stories” for modern cancer treatment with almost all newly diagnosed patients being cured. With such successful outcomes, the focus has now turned to a reduction in the treatment’s side-effects. We are interested in investigating the use of a different method of treating a particular type of testicular cancer, called testicular seminoma, in an attempt to help decrease the side-effects from treatment while preserving the excellent chance for cure.
You are being asked to participate in this survey because you are a member of the Testicular Cancer Society. Participation is voluntary and there is no immediate benefit to you. This survey is designed to help us understand the potential interest in this issue and help in future study design. If you participate in the survey, your consent to participate in this study is conferred by clicking on the link to the survey. To insure your privacy and confidentiality, your responses to this survey will be de-identified and kept anonymous. The survey data will be used both for developing future clinical trials and potential future publication. If you agree to participate in our survey this in no way implies that you would be a patient in such a clinical trial in the future. We are only asking for your response to help us understand what percentage of patients would be interested in such a study.
This study has been granted exempt-status by the University of Colorado Multiple Institutional Review Board. If you have questions about your rights as someone in this study, you are welcome to call the Colorado Multiple Institutional Review Board at (303)724-1055.
Thank you again for your time, and hopefully your participation! Please feel free to contact us using the email address below if there are any questions or concerns.
The link to the survey is as follows: https://www.surveymonkey.com/r/98WCFGQ
Sincerely,
Nicholas Cost, MD
University of Colorado Cancer Center
Comment